List of SBIR/STTR awards granted to SiteOne Therapeutics
SiteOne TherapeuticsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to SiteOne Therapeutics in May, 2021 for $677,568.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HL147776-02 | Phase II | 677,568 | May 10, 2021 | |||||||
A SBIR Phase I contract was awarded to SiteOne Therapeutics in May, 2019 for $226,176.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1U44NS111779-01 | Phase I | 226,176 | May 1, 2019 | |||||||
A SBIR Phase II contract was awarded to SiteOne Therapeutics in May, 2021 for $455,622.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4U44NS111779-03 | Phase II | 455,622 | May 15, 2021 | |||||||
A SBIR Phase I contract was awarded to SiteOne Therapeutics in May, 2019 for $323,733.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL147776-01 | Phase I | 323,733 | May 1, 2019 | |||||||
A SBIR Phase II contract was awarded to SiteOne Therapeutics in September, 2021 for $1,081,115.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44EY033267-01 | Phase II | 1,081,115 | September 1, 2021 | |||||||
A SBIR Phase II contract was awarded to SiteOne Therapeutics in September, 2018 for $1,490,020.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44EY025921-02 | Phase II | 1,490,020 | September 30, 2018 | |||||||
A SBIR Phase II contract was awarded to SiteOne Therapeutics in September, 2016 for $1,446,169.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS081887-04 | Phase II | 1,446,169 | September 1, 2016 | |||||||
A SBIR Phase I contract was awarded to SiteOne Therapeutics in September, 2015 for $223,828.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EY025921-01 | Phase I | 223,828 | September 1, 2015 | |||||||
A SBIR Phase I contract was awarded to SiteOne Therapeutics for $285,048.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM108464-01 | Phase I | 285,048 | ||||||||
A SBIR Phase I contract was awarded to SiteOne Therapeutics for $236,235.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS081887-01 | Phase I | 236,235 |
